Mednax Inc (MD)

Solvency ratios

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial leverage ratio 2.81 2.84 2.82 2.53 2.61 2.40 2.45 2.55 2.63 2.72 2.80 2.67 3.04 3.13 3.16 3.24 4.48 4.26 4.10 2.90

Based on the provided data for Mednax Inc, the solvency ratios reflect a stable and healthy financial position with consistently low levels of debt relative to assets, capital, and equity.

1. Debt-to-assets ratio: The debt-to-assets ratio shows that Mednax Inc has maintained a debt-free position, with a ratio of 0.00 across all reported periods. This indicates that the company's total debt is effectively non-existent in relation to its total assets.

2. Debt-to-capital ratio: Similarly, the debt-to-capital ratio remains constant at 0.00 throughout the given periods. This implies that the company is not using debt significantly to finance its operations, further demonstrating its strong financial position.

3. Debt-to-equity ratio: The debt-to-equity ratio also consistently stands at 0.00, showcasing that the company's reliance on debt to fund its operations is negligible compared to its equity. This suggests a low level of financial risk associated with debt obligations.

4. Financial leverage ratio: The financial leverage ratio has shown a decreasing trend over the periods, starting at 2.90 in March 2020 and gradually declining to 2.81 by December 2024. A lower financial leverage ratio indicates less reliance on debt financing and a stronger equity position, highlighting improved financial stability.

In conclusion, the solvency ratios of Mednax Inc demonstrate a prudent financial strategy focused on maintaining a solid capital structure and minimizing debt levels. This suggests that the company is well-equipped to meet its financial obligations and withstand economic challenges in the long term.


Coverage ratios

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Interest coverage -1.34 -5.51 -5.36 -0.37 -0.24 4.16 4.44 4.95 3.60 3.42 3.18 2.71 3.17 2.42 2.23 1.87 1.55 1.75 1.63 1.72

The interest coverage ratio of Mednax Inc has fluctuated over the analyzed period. Starting at 1.72 in March 2020, the ratio declined to 1.55 by December 2020. However, there was a steady improvement in the ratio from March 2021 to June 2022, reaching a peak of 3.60 in December 2022. This indicated that the company's operating income was sufficient to cover its interest expenses at that time.

Subsequently, there was a decline in the interest coverage ratio from March 2023 to September 2024, dropping to negative values in the last three quarters of 2024. This negative trend suggests that Mednax Inc may have faced challenges in generating enough operating income to cover its interest obligations during this period.

Overall, the trend in Mednax Inc's interest coverage ratio indicates both periods of strength and potential financial difficulties. It is essential for the company to monitor and manage its interest coverage closely to ensure financial stability and meet its debt obligations effectively.